GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: BCD-180 | BCD180
seniprutug is an approved drug
Compound class:
Antibody
Comment: Seniprutug (BCD-180) is a monoclonal antibody that targets T cell receptor beta variable 9 (TRBV9) [1]. It induces antibody-dependent cellular cytotoxicity in the target effector T cell population without causing risk of systemic immunosuppression (that would be caused by destroying T cell subsets that are responsible for essential protective functions).
|
Bioactivity Comments |
We have been unable to find quantitative data to support interaction of this antibody with its proposed molecular target (June 2025). |